The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Carl E. Clarke C

School of Clinical and Experimental Medicine

College of Medical and Dental Sciences

Birmingham

UK

[email]@bham.ac.uk

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • School of Clinical and Experimental Medicine, College of Medical and Dental Sciences, Birmingham, UK. 2010 - 2012
  • Department of Neurology, City Hospital, Sandwell and West Birmingham NHS Trust, Dudley Road, United Kingdom. 2011
  • Department of Neurology, City Hospital, Birmingham, UK. 2000 - 2009
  • Academic Department of Neurology, University of Birmingham and Department of Neurology, Sandwell, UK. 2005
  • Reader in Clinical Neurology, Division of Neuroscience, University of Birmingham and City Hospital, Birmingham, United Kingdom. 2004
  • University of Birmingham, UK. 2004

References

  1. Comparison of speech and language therapy techniques for speech problems in Parkinson's disease. Herd, C.P., Tomlinson, C.L., Deane, K.H., Brady, M.C., Smith, C.H., Sackley, C.M., Clarke, C.E. Cochrane. Database. Syst. Rev (2012) [Pubmed]
  2. Speech and language therapy versus placebo or no intervention for speech problems in Parkinson's disease. Herd, C.P., Tomlinson, C.L., Deane, K.H., Brady, M.C., Smith, C.H., Sackley, C.M., Clarke, C.E. Cochrane. Database. Syst. Rev (2012) [Pubmed]
  3. Should treatment for Parkinson's disease start immediately on diagnosis or delayed until functional disability develops? Clarke, C.E., Patel, S., Ives, N., Rick, C., Wheatley, K., Gray, R. Mov. Disord. (2011) [Pubmed]
  4. Has drug therapy changed the natural history of Parkinson's disease? Clarke, C.E. J. Neurol. (2010) [Pubmed]
  5. Systematic review of apomorphine infusion, levodopa infusion and deep brain stimulation in advanced Parkinson's disease. Clarke, C.E., Worth, P., Grosset, D., Stewart, D. Parkinsonism Relat. Disord. (2009) [Pubmed]
  6. Pilot randomised controlled trial of occupational therapy to optimise independence in Parkinson's disease: the PD OT trial. Clarke, C.E., Furmston, A., Morgan, E., Patel, S., Sackley, C., Walker, M., Bryan, S., Wheatley, K. J. Neurol. Neurosurg. Psychiatr. (2009) [Pubmed]
  7. Are delayed-start design trials to show neuroprotection in Parkinson's disease fundamentally flawed?. Clarke, C.E. Mov. Disord. (2008) [Pubmed]
  8. Rasagiline for motor complications in Parkinson's disease. Clarke, C.E. Lancet (2005) [Pubmed]
  9. Ability of a nurse specialist to diagnose simple headache disorders compared with consultant neurologists. Clarke, C.E., Edwards, J., Nicholl, D.J., Sivaguru, A., Davies, P., Wiskin, C. J. Neurol. Neurosurg. Psychiatr. (2005) [Pubmed]
  10. A "cure" for Parkinson's disease: can neuroprotection be proven with current trial designs?. Clarke, C.E. Mov. Disord. (2004) [Pubmed]
  11. Tremor and deep white matter changes in alpha-methylacyl-CoA racemase deficiency. Clarke, C.E., Alger, S., Preece, M.A., Burdon, M.A., Chavda, S., Denis, S., Ferdinandusse, S., Wanders, R.J. Neurology (2004) [Pubmed]
  12. Neuroprotection and pharmacotherapy for motor symptoms in Parkinson's disease. Clarke, C.E. Lancet. Neurol (2004) [Pubmed]
  13. Beta-blocker therapy for tremor in Parkinson's disease. Crosby, N.J., Deane, K.H., Clarke, C.E. Cochrane. Database. Syst. Rev (2003) [Pubmed]
  14. Amantadine in Parkinson's disease. Crosby, N., Deane, K.H., Clarke, C.E. Cochrane. Database. Syst. Rev (2003) [Pubmed]
  15. Amantadine for dyskinesia in Parkinson's disease. Crosby, N.J., Deane, K.H., Clarke, C.E. Cochrane. Database. Syst. Rev (2003) [Pubmed]
  16. Medical management of Parkinson's disease. Clarke, C.E. J. Neurol. Neurosurg. Psychiatr. (2002) [Pubmed]
  17. Dopamine agonist monotherapy in Parkinson's disease. Clarke, C.E., Guttman, M. Lancet (2002) [Pubmed]
  18. Speech and language therapy for dysarthria in Parkinson's disease. Deane, K.H., Whurr, R., Playford, E.D., Ben-Shlomo, Y., Clarke, C.E. Cochrane. Database. Syst. Rev (2001) [Pubmed]
  19. A comparison of speech and language therapy techniques for dysarthria in Parkinson's disease. Deane, K.H., Whurr, R., Playford, E.D., Ben-Shlomo, Y., Clarke, C.E. Cochrane. Database. Syst. Rev (2001) [Pubmed]
  20. Occupational therapy for patients with Parkinson's disease. Deane, K.H., Ellis-Hill, C., Playford, E.D., Ben-Shlomo, Y., Clarke, C.E. Cochrane. Database. Syst. Rev (2001) [Pubmed]
  21. Physiotherapy for patients with Parkinson's Disease: a comparison of techniques. Deane, K.H., Jones, D., Playford, E.D., Ben-Shlomo, Y., Clarke, C.E. Cochrane. Database. Syst. Rev (2001) [Pubmed]
  22. Systematic review of proton magnetic resonance spectroscopy of the striatum in parkinsonian syndromes. Clarke, C.E., Lowry, M. Eur. J. Neurol. (2001) [Pubmed]
  23. Pergolide for levodopa-induced complications in Parkinson's disease. Clarke C, E., Speller J, M. Cochrane. Database. Syst. Rev (2000) [Pubmed]
  24. Pergolide versus bromocriptine for levodopa-induced motor complications in Parkinson's disease. Clarke C, E., Speller J, M. Cochrane. Database. Syst. Rev (2000) [Pubmed]
  25. Lisuride versus bromocriptine for levodopa-induced complications in Parkinson's disease. Clarke, C.E., Speller, J.M. Cochrane. Database. Syst. Rev (2000) [Pubmed]
  26. Lisuride for levodopa-induced complications in Parkinson's disease. Clarke, C.E., Speller, J.M. Cochrane. Database. Syst. Rev (2000) [Pubmed]
  27. Pramipexole versus bromocriptine for levodopa-induced complications in Parkinson's disease. Clarke C, E., Speller J, M., Clarke J, A. Cochrane. Database. Syst. Rev (2000) [Pubmed]
  28. Pramipexole for levodopa-induced complications in Parkinson's disease. Clarke C, E., Speller J, M., Clarke J, A. Cochrane. Database. Syst. Rev (2000) [Pubmed]
  29. Systematic review of acute levodopa and apomorphine challenge tests in the diagnosis of idiopathic Parkinson's disease. Clarke, C.E., Davies, P. J. Neurol. Neurosurg. Psychiatr. (2000) [Pubmed]
 
WikiGenes - Universities